Galuppo, Roberto <br/><br/>
Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways.  [electronic resource] 

 -  Anticancer research  Apr 2014 
 - 1709-13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Hepatocellular--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Transformation, Neoplastic--metabolism<br/>Disease Models, Animal<br/>Drug Synergism<br/>Female<br/>Humans<br/>Immunophenotyping<br/>Inhibitor of Apoptosis Proteins--metabolism<br/>Liver Neoplasms--metabolism<br/>Mice<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Neoplastic Stem Cells--drug effects<br/>Niacinamide--analogs & derivatives<br/>Phenotype<br/>Phenylurea Compounds--pharmacology<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Proto-Oncogene Proteins p21(ras)--metabolism<br/>Signal Transduction--drug effects<br/>Sorafenib<br/>Sulfonamides--pharmacology<br/>Survivin<br/>Wnt Signaling Pathway--drug effects<br/>raf Kinases--metabolism